About Us
Our Team
Our Advisory Council
Our Members
What is Safer Supply?
Medical and Non-Medical Models of Safer Supply
Why Safer and not Safe?
Our Community of Practice Values and Principles

Guiding Principles for Providing Safer Supply
Land Acknowledgement

“Overdose deaths are preventable” by Millie Schulz
“Overdose deaths are preventable”
 by millie schulz

About Us

The National Safer Supply Community of Practice (NSS-CoP) is a knowledge exchange initiative led by London InterCommunity Health Centre, in partnership with the Canadian Association of People who Use Drugs, the Ontario Aboriginal HIV/AIDS Strategy, and the Alliance for Healthier Communities. It aims to facilitate knowledge exchange, skill-sharing, and capacity building to scale up prescribed safer supply programs across Canada.

The NSS-CoP supports healthcare and social service providers as they provide a continuum of care options for people who use drugs at high risk of overdose and death. As the need continues to grow for safer supply, the NSS-CoP serves as a resource for those who would benefit from learning about how to deliver care within a harm reduction framework in community health settings. However, this is not a teaching space - but rather a space where health and social care providers and people with living/lived experience exchange information, including clinical experiences, program operations, evidence, and
personal experiences.

Our work is grounded in an anti-oppression and anti-racism framework and anchored on core values of respect, collaboration, equity, integrity, and curiosity.

Join us!

Our Team

The NSS-CoP team consists of knowledge mobilization specialists, a project administrator, and a project manager. Learn more about our team.

Our Advisory Council

Our Advisory Council informs the strategic direction and activities of the NSS-CoP and provides direction and feedback to the NSS-CoP Team. Members of our Advisory Council hold diverse and intersecting roles and positions including clinicians, social care providers, people who use(d) drugs, harm reduction workers, and researchers.

Our Members

Our interdisciplinary community of over 1,500 members includes pharmacists, physicians and physician assistants, nurses and nurse practitioners, social care providers, advocates and activists, people who use(d) drugs, researchers, policy makers, and many others. Collectively, we form a space where healthcare and social service providers and people who use(d) drugs exchange information including clinical experiences, program operational experiences, and personal experiences. Join us now!

What is Safer Supply?

Between 2016 and 2022, 36,442 people died from consuming unregulated drugs across Canada. In 2022 alone, 7,328 people died – a staggering rate of approximately 20 people dying each per day.

We can prevent the loss of people’s lives by changing drug policies that criminalize, stigmatize, and marginalize people who use drugs. We can prevent harms, including death, by ensuring that people have access to a safer supply of regulated drugs of known quality and potency.

Safer supply programs are an approach to addressing this ongoing health crisis by:

  • providing a pharmaceutical grade medication as an alternative to the unpredictable and potent unregulated street supply
  • working from a harm reduction approach that puts the needs and goals of people who use drugs at the forefront and improving access to non-stigmatizing healthcare and social services for people who use drugs

Prescribed safer supply reduces overdose risk and improves the health and wellness of people who use drugs.

The goals of safer supply are to:

  • reduce people’s overdose risk and other harms arising from the unregulated street supply and the criminalization and stigmatization of drugs;
  • increase people’s autonomy and control over their substance use; and, 
  • improve the health and wellness of people who use drugs.

Calls for a safe supply of drugs are not new, and people who use(d) drugs and healthcare professionals have been engaged in this work for decades now. Emerging evidence shows that prescribed safer supply saves lives and improves quality of life.

For more information about prescribed safer supply programs, please see Prescribed Safer Supply: Frequently Asked Questions.

Medical and Non-Medical Models of Safer Supply

There are different models for the provision of safer supply. A medical model makes use of regulated health professionals’ ability to prescribe pharmaceutical drugs within the context of a healthcare provider-client relationship. A medical model can be implemented in different ways, drawing on different approaches such as a “treatment” focus or a “harm reduction” focus. Current approaches include injectable opioid agonist treatment (iOAT; observed dosing); daily dispensed; and vending machines. For more information on safer supply models, please refer to Glegg et al., 2022.

The NSS-CoP focuses on a medicalized model of safer supply rooted in harm reduction because, in the current legal and regulatory context, it is possible to scale up quickly. Tensions between harm reduction and medicalized models create challenges, but together we strive to promote medical models that are people-centred, lower-barrier, and uphold people who use drugs as experts and that create space for them to be leaders and service providers. While a medical model fills a current gap on the continuum of care for people who use drugs, we know it is insufficient to meet the diverse needs of people who use drugs. We are committed to supporting policy change that enables the implementation of non-medical, community-led models of safer supply, as well as decriminalization, and regulation.

For more information about safer supply and its different models, please see CAPUD’s Safe Supply Concept Document, our Prescribed Safer Supply: Frequently Asked Questions document, our Emerging Evidence Brief on Prescribed Alternatives Programs, and additional Resources.

Why Safer and not Safe?

You may have noticed that we use the term “safer supply” as opposed to “safe supply”. There are several reasons for this positioning.

First, the term “safe supply” comes from the drug user movement. The current medicalized model does not reflect their vision of safe supply. The protocols and policies of current medicalized programs and the types of medications they provide do not adequately or appropriately address the diverse and expressed needs of people who use drugs. A medicalized model is only accessible to people who are diagnosed as having a substance use disorder, abandoning those who use substances recreationally or intermittently. Because medicalized models do not adequately address diverse needs, people who use drugs must rely on unregulated, toxic drug supplies, putting them at risk of drug-poisoning and overdose and death. Ultimately, “safe” supply as outlined by the drug user movement, has yet to be legally realized. For more information about their concept of safe supply, please see CAPUD’s Safe Supply Concept Document.

Additionally, Health Canada and medicalized programs use the term “safer supply” to acknowledge that the use of opioids (and medications in general) always comes with some risks and so cannot be called “safe”. However, “safer” works to acknowledge that a drug of known quality, composition, and potency is less risky than drugs purchased on the street from an unregulated market.

Our Community of Practice Values and Principles

Respect: We consider respect as fundamental for engaging in our community of practice. Respect is the feeling of regarding someone well for their qualities and traits, but respect is also the action of treating people with appreciation and dignity. We value all people and firmly believe each person deserves dignity, agency, and independence. This means honoring someone by demonstrating care, concern, or consideration for their needs and feelings. This includes being supportive, fostering people’s autonomy and freedom, and nurturing a community of practice built on solidarity, care, and compassion.

Collaboration: Our community of practice is built on interdisciplinary collaboration. Collaboration happens when people, groups, and/or organizations work together to achieve common, shared goals. Our interdisciplinary membership – physicians and physician assistants, nurse practitioners, nurses, people who use(d) drugs, harm reduction workers, researchers, program managers, policy analysts, and activists – come together to learn collectively from one another, build capacity and engage in skill-sharing opportunities, and develop shared practices. As a diverse membership, we uphold all sources of knowledge and value everyone’s individual expertise. Our collaborations also aim to be power aware by continually challenging the intricate power dynamics and imbalances that exist within and across groups. By working collaboratively, we can better share resources, coordinate key messaging, uplift each other’s work, build collective solidarity, and bolster community resistance.

Equity: We strive for equity in all facets of our community of practice. Equity means recognizing that we do not all start from the same place and that some people and groups disproportionately experience higher levels of oppression, trauma, stigma, and social and structural violence. We are committed to acknowledging this and making adjustments in our work and relationships to address these imbalances and injustices. We learn from an anti-colonial, anti-oppression, and anti-racism framework rooted in a spirit of reciprocity and prioritize social justice above all else. We aim to foster feelings of safety, belonging, support, and fairness for all community members holding diverse and intersecting identities, perspectives, and experiences. We equally work to ensure inclusivity, accessibility, and disability justice in our community of practice. This includes providing access to closed captioning and alternative text, publishing documents in various accessible formats, and developing user-friendly content.

Integrity: Integrity is a practice that includes being honest and showing a consistent commitment to strong moral and ethical principles and values. We know trust is earned and believe that the earnestness of our actions demonstrate our commitment to social justice, equity, and community accountability. This means we are accountable for our actions, take responsibility for our wrongdoings, find ways to remedy our errors, and maintain transparency in all of our work. We also acknowledge relationships are reciprocal and know we can strengthen our community by equitably sharing skills, exchanging resources, and offering mutual support.

Curiosity: Our community of practice thrives on the spirit of curiosity, generosity, progress, and positive change. Curiosity involves being open to exploration, investigation, learning, and critical thinking. By remaining curious, we nurture feelings of acceptance, normalcy, compassion, non-judgement, and understanding among our members. Questioning, analyzing, and challenging assumptions through our diverse perspectives and lenses helps us work towards transforming health care practices and policies to centre people who use drugs as leaders and experts in their own care. This means remaining committed to being compassionately inquisitive, asking difficult questions, sitting with and discussing discomforts, wrongdoings, and injustices, and navigating disagreements with openness, respect, and a desire to understand.

Guiding Principles for Providing Safer Supply

We endorse the guiding principles for providing safer supply that are presented in the guiding document: Safer Opioid Supply Programs (SOS): A Harm Reduction Informed Guiding Document for Primary Care Teams (Hales et al., 2020). These principles are:

People who use drugs are experts

People who use drugs are knowledgeable about the culture of drug use and their own goals and needs. Collaborating with people who use drugs is critical to developing successful programs and strategies to address the ongoing unregulated drug toxicity crisis. Their expertise should guide the development, implementation, and evaluation of all safer supply programs.

Participant-led and participant-centred care delivery

Programs will aim to support people to meet their current goals for drug use in the safest way possible. The aim is to provide compassionate and equitable health care to all people who use drugs.

Harm reduction

Programs will recognize that drug-related harms stem from several different sources, primarily from the criminalization of people who use, share, and sell drugs. Programs aim to reduce some of the harms associated with drug use by providing a regulated, safer drug supply. Clinicians will respect people’s autonomy, agency, and choices around drug use and accessing healthcare.

Lower-barrier care

Programs will be as accessible as possible. Clinicians will strive to meet participant needs and ensure access to a continuum of care through flexibility, problem solving, and collaboration.

Non-punitive approach

Missed doses or assessments or continued use of the unregulated drug supply will be addressed with compassion through dialogue and support and will not result in discharge from the program.

Land Acknowledgement

We come together in this community of practice from across Turtle Island, as people who live on treaty lands and ceded and unceded territories. We are all treaty people.

Our team is comprised of individuals and organizations from across Turtle Island, including the traditional lands of the Anishinaabek, Haudenosaunee, Lūnaapéewak and Attawandaron, on lands connected with the London Township and Sombra Treaties of 1796 and the Dish with One Spoon Covenant Wampum (London); the territories of the Mississaugas of the Credit, Anishnabeg, the Chippewa, Haudenosaunee and Wendat peoples, covered by Treaty 13 signed with the Mississaugas of the Credit and the Williams Treaties, signed with multiple Mississaugas and Chippewa bands (Toronto); on the lands covered by Treaties 16 and 18, which are territories of the Huron-Wendat, Haudenosaunee, and Anishinaabeg peoples (Barrie); in Alderville, home to the Mississauga Anishinabeg of the Ojibway Nation; in Tiohtià:ke (Montréal), which is located on the unceded territories of the Kanien’kehá:ka Nation; and in Ponamogoatitjg and Sogumkeagum (Dartmouth and Shelburne, Nova Scotia), the traditional and ongoing lands of the Mi’kmaq.

We work in a sector whose goal is to address social and structural harms. We recognize that the production of these harms comes from our colonial history and its enduring practices, institutions, and ways of thinking in our ongoing daily lives. We know that Indigenous people, as well as members of the African, Caribbean, and Black communities, are disproportionately harmed and criminalized by drug policies that are rooted in racism and colonialism.

Colonialism is with us today, and we commit to working in ways that transform racist and colonial institutions and practices, to repair harms, prevent future harms, and to work towards a more inclusive and equitable future.